Results 1 to 10 of about 11,553 (254)

Displacement of impella post chest compressions

open access: yesHeart Views, 2014
The Impella is a left ventricular assist device which is implanted via the transcutaneous femoral route and is placed across the aortic valve into the left ventricle.
Sourabh Aġġarwal, Susan Bannon
doaj   +3 more sources

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study

open access: yesJournal of Cardiovascular Development and Disease, 2023
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion.
Beatrice De Lazzari   +4 more
doaj   +1 more source

Transaxillary implantation of the Impella CP mechanical circulatory support device as a bridge to heart transplant: first experience in Spain [PDF]

open access: yes, 2017
Carta ...
Couto-Mallón, David   +5 more
core   +2 more sources

Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. Case presentation We report three cases of successful intensive treatment by Impella of FM without any complications.
Takayuki Hori   +3 more
doaj   +1 more source

Right ventricular failure: Current strategies and future development

open access: yesFrontiers in Cardiovascular Medicine, 2023
Right heart failure can be defined as a clinical syndrome consisting of signs and symptoms of heart failure resulting from right ventricular dysfunction. Function is normally altered due to three mechanisms: (1) pressure overload (2) volume overload, or (
María Monteagudo-Vela   +7 more
doaj   +1 more source

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock.

open access: yesPLoS ONE, 2020
BackgroundIn selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella may be beneficial, although conclusive evidence is still lacking.
Veemal V Hemradj   +17 more
doaj   +1 more source

Impella as unloading strategy during VA-ECMO: systematic review and meta-analysis

open access: yesReviews in Cardiovascular Medicine, 2021
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used as mechanical circulatory support in cardiogenic shock (CS). It restores peripheral perfusion, at the expense of increased left ventricle (LV) afterload.
Francesca Fiorelli   +1 more
doaj   +1 more source

Initial experience with Imacor hTEE-guided management of patients following transplant and mechanical circulatory support. [PDF]

open access: yes, 2012
We reviewed an initial experience using a miniaturized transesophageal echocardiography (TEE) probe (ImaCor, Garden City, NY) with 3 patients in whom Imacor hTEE intervention was used as a point of care device to manage extracorporeal membrane ...
,   +3 more
core   +2 more sources

Heart Rate Variability: A possible machine learning biomarker for mechanical circulatory device complications and heart recovery [PDF]

open access: yes, 2020
Cardiovascular disease continues to be the number one cause of death in the United States, with heart failure patients expected to increase to \u3e8 million by 2030.
Aras, Shravan   +2 more
core   +1 more source

Current state-of-the-art of device therapy for advanced heart failure [PDF]

open access: yes, 2014
Heart failure remains one of the most common causes of morbidity and mortality worldwide. The advent of mechanical circulatory support devices has allowed significant improvements in patient survival and quality of life for those with advanced or end ...
Lee, Lawrence S., Shekar, Prem S.
core   +2 more sources

Home - About - Disclaimer - Privacy